Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia

BACKGROUND: The combination of ezetimibe with statin therapy reduced cardiovascular events compared to statin monotherapy in IMPROVEIT study, and ezetimibe monotherapy attenuated atherosclerosis in basic study. We previously showed ezetimibe monotherapy was especially effective for metabolic syndrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Tano, Kanako, Suematsu, Yasunori, Tashiro, Kohei, Kumagai-Koyanagi, Naoko, Matsuo, Yoshino, Kuwano, Takashi, Miura, Shin-ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785278/
https://www.ncbi.nlm.nih.gov/pubmed/31636781
http://dx.doi.org/10.14740/jocmr3901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785278/
https://www.ncbi.nlm.nih.gov/pubmed/31636781
http://dx.doi.org/10.14740/jocmr3901

Ejemplares similares